Ajay Malik, PhD

All articles by Ajay Malik, PhD

Vemurafenib for Melanoma and Other Cancers

Ajay Malik, PhD

January 25, 2012

One of the major cancer medicine success stories of 2011 was the FDA approval of vemurafenib (Zelboraf ®; Genentech/Daiichi Sankyo) for metastatic melanoma.

Next post in Skin Cancer

Ajay Malik, PhD

All articles by Ajay Malik, PhD

Vemurafenib for Melanoma and Other Cancers

No Mitotic Difference in Single or Multiple Primary Melanomas